More articles from Preclinical Probes for Oncology

You have access
Fluorine-18 labeled fibroblast activation protein alpha targeting ligand: In vitro and in vivo studies.
Jyoti Roy, Elaine Jagoda, Falguni Basuli, Colleen Olkowski, Xiang Zhang, Karen Wong, Carolyn woodroofe, Rolf Swenson, Peter Choyke and Frank Lin

Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 1468;
You have access
Therapeutic efficacy of single-dose iso-[²¹¹At]SAGMB-anti-HER2 sdAb in mice with subcutaneous HER2-expressing breast carcinoma xenografts
Yutian Feng, Stephen Jannetti, Rebecca Meshaw, Ganesan Vaidyanathan and Michael Zalutsky

Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 1484;
You have access
Preclinical Evaluation of ¹⁸F-VS-PSMAs as New Prostate-Specific Membrane Antigen Ligands for Prostate Cancer Imaging
Tao Zhang, Jinghua Cai, Hui Wang, Jianhua Cai, Mengzhe Wang, Zhaoguo Han, Eric Smith, Zhanhong Wu and Zibo Li

Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 1506;
You have access
²²⁷Th Labeled 3,4,3-(LI-1,2-HOPO): Optimized Synthesis, Biological Distribution and Dosimetry.
Vanessa Sanders, Edwin Pratt, N.V.S. Dinesh Bhupathiraju, Lukas Carter, Jannatul Ferdous, Bernadette Marquez-Nostra, David Schlyer, Jason Lewis, Lynn Francesconi and Cathy Cutler

Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 1482;
You have access
Pre-targeted immuno-PET based on bioorthogonal chemistry for imaging PD-1 positive non-small cell lung cancer
Xudong Shi, Kai Gao and Ran Gao

Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 1518;
You have access
Determination of the radioimmunoreactivity for anti-CD66-antibody therapy
Gordon Winter, Jessica Loeffler, Gabriel Fischer, Christoph Solbach, Peter Kletting, Ambros Beer and Gerhard Glatting

Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 1478;
You have access
C-C Chemokine Receptor Type 2-Targeting Ultrasmall Copper Nanoparticles for Positron Emission Tomography-Guided Delivery of Gemcitabine for Pancreatic Ductal Adenocarcinoma
Xiaohui Zhang, Lisa Detering, Deborah Sultan, Hannah Luehmann, Lin Li, Gyu Seong Heo, Xiuli Zhang, Lanlan Lou, Patrick Grierson, Suellen Greco, Marianna Ruzinova, Richard Laforest, Farrokh Dehdashti, Kian-Huat Lim and Yongjian Liu

Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 1469;
You have access
Baseline 18F fluorodeoxyglucose(FDG)-positron emission tomography (PET) in patient derived (PD) xenograft models from the National Cancer Institute Patient Derived Model Repository (PDMR).
Paula Jacobs, James Tatum, Joseph Kalen, Lisa Riffle, Nimit Patel, Jessica Phillips, Melinda Hollingshead, Yvonne Evrard, Michelle Gottholm-Ahalt, Chelsea Sanders, Simone Difilippantonio and James Doroshow

Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 1470;
You have access
PET imaging of PD-L1 using anti-PD-L1-B11 antibody in breast cancer tumor model
Aditya Bansal, Whitney Barham, Xin Liu, Susan Harrington, Fabrice Lucien-Matteoni, Haidong Dong, Sean Park, Mukesh Pandey and Timothy DeGrado

Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 1486;
You have access
^99mTc-HYNIC-diabody targeting transferrin receptor for tumor imaging
Yong He and Lei Dai

Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 1502;

Main menu

User menu

Search

More articles from Preclinical Probes for Oncology

Pages